ZYXI

Zynex, Inc. [ZYXI] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ZYXI Stock Summary

Top 10 Correlated ETFs

ZYXI


Top 10 Correlated Stocks

ZYXI


In the News

09:15 29 Sep 2023 ZYXI

Zynex to Present at the Cantor Global Healthcare Conference

ENGLEWOOD, Colo. , Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming Cantor Global Healthcare Conference, which is being held September 26 th-28th, 2023.

09:15 29 Sep 2023 ZYXI

Zynex to Present at the H.C. Wainwright Global Investment Conference

ENGLEWOOD, Colo., Sept. 5, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming H.C.

08:14 29 Sep 2023 ZYXI

Zynex, Inc. (ZYXI) Q2 2023 Earnings Call Transcript

Zynex, Inc. (NASDAQ:ZYXI ) Q2 2023 Earnings Conference Call July 27, 2023 4:15 PM ET Company Participants Quinn Callanan - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive Officer Anna Lucsok - Chief Operating Officer Donald Gregg - Vice President, Zynex Monitoring Solutions Daniel Moorhead - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good day ladies and gentlemen, and welcome to the Zynex Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

06:28 29 Sep 2023 ZYXI

Zynex Inc. (ZYXI) Q2 Earnings and Revenues Surpass Estimates

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.08 per share a year ago.

09:15 29 Sep 2023 ZYXI

Zynex, Inc. Sets Second Quarter 2023 Earnings Call

ENGLEWOOD, Colo. , July 20, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 27, 2023 at 4:15 PM Eastern Time to discuss its financial results for the second quarter, 2023 ended June 30, 2023.

03:33 29 Sep 2023 ZYXI

Zynex: Strong Growth And Profitability Amid Financial Concerns

Zynex, a medical device manufacturer, has reported a 36% year-over-year increase in revenue in Q1 2023, reaching $42.2 million, with a 14% increase in net income. Despite short-term underperformance, the company shows strong profitability and growth potential, with a gross profit margin of nearly 80% and a substantial return on equity of 24.58%. Zynex's robust growth strategy and commitment to operational efficiency suggest a promising outlook, despite concerns related to its financial stability and stock performance.

12:33 29 Sep 2023 ZYXI

Why Shares of Zynex Are Up Wednesday

Zynek makes electrotherapy devices to control pain. The company grew revenue and net income in the first quarter.

06:34 29 Sep 2023 ZYXI

7 Stocks With 1,000% Upside Potential

While market advocates will wince at accusations that investing is nothing more than legalized gambling, for these stocks with massive upside potential, I for one will have to concede that only speculators should read ahead. Though these enterprises may have yield lifechanging returns, they can quickly leave you in the poor house.

02:49 29 Sep 2023 ZYXI

Zynex, Inc. (ZYXI) Q1 2023 Earnings Call Transcript

Zynex, Inc. (NASDAQ:ZYXI ) Q1 2023 Earnings Conference Call April 27, 2023 4:15 PM ET Company Participants Louisa Smith - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive Officer Anna Lucsok - Chief Operating Officer Donald Gregg - Vice President, Zynex Monitoring Solutions Daniel Moorhead - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Adam Maeder - Piper Sandler Yi Chen - H.C. Wainwright Operator Good afternoon, ladies and gentlemen, and welcome to the Zynex First Quarter 2023 Earnings Conference Call.

07:00 29 Sep 2023 ZYXI

Zynex Inc. (ZYXI) Beats Q1 Earnings and Revenue Estimates

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.03 per share a year ago.

ZYXI Financial details

Company Rating
Strong Buy
Market Cap
295.89M
Income
17.25M
Revenue
177.45M
Book val./share
1.71
Cash/share
1.61
Dividend
-
Dividend %
-
Employees
900
Optionable
No
Shortable
Yes
Earnings
25 Oct 2023
P/E
17.39
Forward P/E
-
PEG
61.14
P/S
1.63
P/B
4.82
P/C
5.13
P/FCF
20.28
Quick Ratio
6.51
Current Ratio
7.63
Debt / Equity
1.15
LT Debt / Equity
1.11
-
-
EPS (TTM)
0.46
EPS next Y
-
EPS next Q
0.11
EPS this Y
-2.22%
EPS next Y
-
EPS next 5Y
1.56%
EPS last 5Y
10.26%
Revenue last 5Y
37.73%
Revenue Q/Q
6.6%
EPS Q/Q
110.28%
-
-
-
-
SMA20
-
SMA50
-11.11%
SMA100
-27.27%
Inst Own
35.18%
Inst Trans
1.19%
ROA
11%
ROE
27%
ROC
0.15%
Gross Margin
80%
Oper. Margin
12%
Profit Margin
10%
Payout
-
Shs Outstand
35.1M
Shs Float
19.33M
-
-
-
-
Target Price
18
52W Range
6.88-17.25
52W High
-51.38%
52W Low
+37.75%
RSI
55
Rel Volume
0.44
Avg Volume
391.74K
Volume
171.6K
Perf Week
2.93%
Perf Month
8.18%
Perf Quarter
-30.02%
Perf Half Y
-27.37%
-
-
-
-
Beta
0.632088
-
-
Volatility
0.08%, 0.41%
Prev Close
0.43%
Price
8.265
Change
0.79%

ZYXI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
0.891.272.153.44.11
Net income per share
0.270.270.240.450.44
Operating cash flow per share
0.260.180.020.180.36
Free cash flow per share
0.230.1700.170.35
Cash per share
0.280.391.051.110.52
Book value per share
0.260.551.531.931.73
Tangible book value per share
0.260.551.531.140.96
Share holders equity per share
0.260.551.531.931.73
Interest debt per share
00.130.20.920.71
Market cap
94.54M255.29M455.88M347.29M535.08M
Enterprise value
84.41M245.94M424.04M339.77M541.89M
P/E ratio
9.926.950.2420.3131.39
Price to sales ratio
2.965.615.692.673.38
POCF ratio
10.0540.5557.3149.9838.93
PFCF ratio
11.3641.56-2.73K54.7840.15
P/B Ratio
10.0712.938.024.78.06
PTB ratio
10.0712.938.024.78.06
EV to sales
2.645.415.292.613.43
Enterprise value over EBITDA
8.1422.2236.1115.1923.62
EV to operating cash flow
8.9739.02518.3848.8939.42
EV to free cash flow
10.1440.04-2.54K53.5940.66
Earnings yield
0.10.040.020.050.03
Free cash flow yield
0.090.0200.020.02
Debt to equity
00.240.130.470.41
Debt to assets
00.170.10.260.23
Net debt to EBITDA
-0.98-0.85-2.71-0.340.3
Current ratio
2.254.346.233.623.3
Interest coverage
67.342.21K539.42235.4352.13
Income quality
0.980.660.090.410.81
Dividend Yield
00.01000.01
Payout ratio
00.24000.21
Sales general and administrative to revenue
00.250.230.20.23
Research and developement to revenue
00000
Intangibles to total assets
0000.230.25
Capex to operating cash flow
-0.12-0.03-1.2-0.09-0.03
Capex to revenue
-0.030-0.0100
Capex to depreciation
-2.42-0.21-0.63-0.27-0.13
Stock based compensation to revenue
0.010.020.030.010.01
Graham number
1.261.822.894.44.15
ROIC
1.030.30.130.130.16
Return on tangible assets
0.590.340.130.170.2
Graham Net
0.160.311.030.260.08
Working capital
7.97M17.37M52.91M59.82M48.47M
Tangible asset value
9.3M19.65M56.86M43.55M36.89M
Net current asset value
7.44M13.94M47.7M23.34M19.45M
Invested capital
00.240.130.470.41
Average receivables
2.49M4.31M9.84M21.23M31.85M
Average payables
1.9M1.84M3.43M4.73M5.17M
Average inventory
630K1.61M5.51M9.7M12.12M
Days sales outstanding
31.9246.8263.0480.280.91
Days payables outstanding
93.8288.3398.8563.3163.88
Days of inventory on hand
50.698.48180.96143.7153.78
Receivables turnover
11.447.85.794.554.51
Payables turnover
3.894.133.695.775.71
Inventory turnover
7.213.712.022.542.37
ROE
1.020.480.160.230.26
Capex per share
-0.030-0.03-0.02-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
0.951.091.311.151.23
Net income per share
0.090.130.20.040.09
Operating cash flow per share
00.190.130.050.02
Free cash flow per share
-0.010.190.130.050.01
Cash per share
0.690.620.540.461.61
Book value per share
1.781.711.781.761.71
Tangible book value per share
1.010.930.990.960.91
Share holders equity per share
1.781.711.781.761.71
Interest debt per share
0.80.770.730.671.97
Market cap
310.03M345.08M517.95M440.33M349.41M
Enterprise value
314.14M350.73M524.77M447.91M362.01M
P/E ratio
23.1617.717.3870.1626.04
Price to sales ratio
8.438.3110.6110.447.77
POCF ratio
-1.76K46.56108.88227.68471.54
PFCF ratio
-981.1147.33110.89251.62658.03
P/B Ratio
4.495.297.816.835.61
PTB ratio
4.495.297.816.835.61
EV to sales
8.558.4510.7510.628.05
Enterprise value over EBITDA
62.5747.6751.91177.1895.27
EV to operating cash flow
-1.78K47.32110.31231.6488.55
EV to free cash flow
-994.1348.1112.35255.95681.76
Earnings yield
0.010.010.0100.01
Free cash flow yield
00.020.0100
Debt to equity
0.450.450.410.381.15
Debt to assets
0.260.250.230.220.47
Net debt to EBITDA
0.820.770.6733.32
Current ratio
3.753.413.33.097.63
Interest coverage
37.9561.87106.4220.058.56
Income quality
-0.051.520.641.230.22
Dividend Yield
0.010000
Payout ratio
1.080000
Sales general and administrative to revenue
0.240.230.210.270.25
Research and developement to revenue
00000
Intangibles to total assets
0.250.260.250.260.19
Capex to operating cash flow
0.8-0.02-0.02-0.1-0.28
Capex to revenue
00000
Capex to depreciation
-0.18-0.15-0.1-0.22-0.19
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
1.862.222.831.31.88
ROIC
0.030.050.070.020.02
Return on tangible assets
0.040.060.090.020.03
Graham Net
0.110.050.080.040.01
Working capital
51.81M47.61M48.47M44.11M93.47M
Tangible asset value
39.08M35.49M36.89M35.24M33.25M
Net current asset value
20.06M17.13M19.45M18.6M17.26M
Invested capital
0.450.450.410.381.15
Average receivables
27.83M28.09M31.71M33.56M32.51M
Average payables
5.89M5.19M5.37M5.63M5.79M
Average inventory
14.03M14.47M13.93M13.83M14.25M
Days sales outstanding
68.1261.4564.6668.4265.98
Days payables outstanding
64.5155.1253.754.8657.56
Days of inventory on hand
179.53154.09129.27137.72139.05
Receivables turnover
1.321.461.391.321.36
Payables turnover
1.41.631.681.641.56
Inventory turnover
0.50.580.70.650.65
ROE
0.050.070.110.020.05
Capex per share
000-0.01-0.01

ZYXI Frequently Asked Questions

What is Zynex, Inc. stock symbol ?

Zynex, Inc. is a US stock , located in Englewood of Co and trading under the symbol ZYXI

Is Zynex, Inc. buy or a sell ?

2 stock analysts have 2 predictions with a medium analyst target price of $12.5. The lowest prediction is $7 and the highest is $18

What is ZYXI stock prediction ?

What is Zynex, Inc. stock quote today ?

Zynex, Inc. stock price is $8.265 today.

Is Zynex, Inc. stock public?

Yes, Zynex, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap